KR102338667B1 - 연속혈당측정용 센서트랜스미터의 제조 방법 - Google Patents
연속혈당측정용 센서트랜스미터의 제조 방법 Download PDFInfo
- Publication number
- KR102338667B1 KR102338667B1 KR1020200030306A KR20200030306A KR102338667B1 KR 102338667 B1 KR102338667 B1 KR 102338667B1 KR 1020200030306 A KR1020200030306 A KR 1020200030306A KR 20200030306 A KR20200030306 A KR 20200030306A KR 102338667 B1 KR102338667 B1 KR 102338667B1
- Authority
- KR
- South Korea
- Prior art keywords
- transmitter
- sensor
- blood glucose
- information
- glucose measurement
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 142
- 238000000034 method Methods 0.000 title claims abstract description 22
- 239000008280 blood Substances 0.000 claims abstract description 207
- 210000004369 blood Anatomy 0.000 claims abstract description 207
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 198
- 239000008103 glucose Substances 0.000 claims abstract description 198
- 238000005259 measurement Methods 0.000 claims abstract description 155
- 238000003908 quality control method Methods 0.000 claims abstract description 53
- 238000004891 communication Methods 0.000 claims description 52
- 238000013507 mapping Methods 0.000 claims description 6
- 238000009826 distribution Methods 0.000 abstract description 7
- 230000002950 deficient Effects 0.000 abstract description 6
- 206010012601 diabetes mellitus Diseases 0.000 description 13
- 238000010586 diagram Methods 0.000 description 8
- 238000003860 storage Methods 0.000 description 8
- 210000001124 body fluid Anatomy 0.000 description 7
- 239000010839 body fluid Substances 0.000 description 6
- 238000004806 packaging method and process Methods 0.000 description 5
- 230000002218 hypoglycaemic effect Effects 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 3
- 230000005856 abnormality Effects 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 239000002390 adhesive tape Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 238000009516 primary packaging Methods 0.000 description 2
- 238000009517 secondary packaging Methods 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010017711 Gangrene Diseases 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 206010047571 Visual impairment Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000003345 hyperglycaemic effect Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000000663 muscle cell Anatomy 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 238000012858 packaging process Methods 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 208000028169 periodontal disease Diseases 0.000 description 1
- 208000022530 polyphagia Diseases 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 208000029257 vision disease Diseases 0.000 description 1
- 230000004393 visual impairment Effects 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 208000016261 weight loss Diseases 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G05—CONTROLLING; REGULATING
- G05B—CONTROL OR REGULATING SYSTEMS IN GENERAL; FUNCTIONAL ELEMENTS OF SUCH SYSTEMS; MONITORING OR TESTING ARRANGEMENTS FOR SUCH SYSTEMS OR ELEMENTS
- G05B19/00—Programme-control systems
- G05B19/02—Programme-control systems electric
- G05B19/418—Total factory control, i.e. centrally controlling a plurality of machines, e.g. direct or distributed numerical control [DNC], flexible manufacturing systems [FMS], integrated manufacturing systems [IMS] or computer integrated manufacturing [CIM]
- G05B19/41875—Total factory control, i.e. centrally controlling a plurality of machines, e.g. direct or distributed numerical control [DNC], flexible manufacturing systems [FMS], integrated manufacturing systems [IMS] or computer integrated manufacturing [CIM] characterised by quality surveillance of production
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q10/00—Administration; Management
- G06Q10/06—Resources, workflows, human or project management; Enterprise or organisation planning; Enterprise or organisation modelling
- G06Q10/063—Operations research, analysis or management
- G06Q10/0639—Performance analysis of employees; Performance analysis of enterprise or organisation operations
- G06Q10/06395—Quality analysis or management
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06K—GRAPHICAL DATA READING; PRESENTATION OF DATA; RECORD CARRIERS; HANDLING RECORD CARRIERS
- G06K19/00—Record carriers for use with machines and with at least a part designed to carry digital markings
- G06K19/06—Record carriers for use with machines and with at least a part designed to carry digital markings characterised by the kind of the digital marking, e.g. shape, nature, code
- G06K19/06009—Record carriers for use with machines and with at least a part designed to carry digital markings characterised by the kind of the digital marking, e.g. shape, nature, code with optically detectable marking
- G06K19/06037—Record carriers for use with machines and with at least a part designed to carry digital markings characterised by the kind of the digital marking, e.g. shape, nature, code with optically detectable marking multi-dimensional coding
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q10/00—Administration; Management
- G06Q10/08—Logistics, e.g. warehousing, loading or distribution; Inventory or stock management
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/08—Sensors provided with means for identification, e.g. barcodes or memory chips
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/12—Manufacturing methods specially adapted for producing sensors for in-vivo measurements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- G—PHYSICS
- G05—CONTROLLING; REGULATING
- G05B—CONTROL OR REGULATING SYSTEMS IN GENERAL; FUNCTIONAL ELEMENTS OF SUCH SYSTEMS; MONITORING OR TESTING ARRANGEMENTS FOR SUCH SYSTEMS OR ELEMENTS
- G05B2219/00—Program-control systems
- G05B2219/30—Nc systems
- G05B2219/32—Operator till task planning
- G05B2219/32368—Quality control
Landscapes
- Business, Economics & Management (AREA)
- Engineering & Computer Science (AREA)
- Human Resources & Organizations (AREA)
- Economics (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Development Economics (AREA)
- Entrepreneurship & Innovation (AREA)
- Strategic Management (AREA)
- Theoretical Computer Science (AREA)
- Quality & Reliability (AREA)
- Tourism & Hospitality (AREA)
- General Business, Economics & Management (AREA)
- Operations Research (AREA)
- Marketing (AREA)
- Educational Administration (AREA)
- Game Theory and Decision Science (AREA)
- General Engineering & Computer Science (AREA)
- Manufacturing & Machinery (AREA)
- Automation & Control Theory (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Management, Administration, Business Operations System, And Electronic Commerce (AREA)
Abstract
Description
도 2 및 도 3는 연속혈당측정용 센서트랜스미터를 어플리케이터를 이용하여 인체에 부착하는 과정을 설명하기 위한 도면이다.
도 4는 본 발명에 따른 연속혈당측정용 센서트랜스미터의 제조 공정을 설명하기 위한 도면이다.
도 5는 트레이(230)에 담겨진 센서와 트랜스미터의 일 예를 도시하고 있다.
도 6은 본 발명에서 제조 단말기, 관리 서버 및 통신 단말기 사이에서 송수신되는 메시지를 설명하기 위한 도면이다.
도 7은 본 발명에 따라 관리 서버에 저장되는 품질 관리 정보의 일 예를 도시하고 있다.
도 8은 본 발명에 따른 제조 단말기의 일 예를 설명하기 위한 기능 블록도이다.
도 9는 본 발명에 따른 연속혈당측정용 센서트랜스미터의 제조 방법을 설명하기 위한 흐름도이다.
110: 센서 정보 획득부 130: 트랜스미터 정보 획득부
150: 정보 생성부 170: 저장부
180: 제어부 190: 통신부
210: 이송벨트 230: 트레이
241: 센서 243: 트랜스미터
Claims (8)
- 연속혈당측정용 센서트랜스미터의 제조 방법에 있어서,
센서 정보 획득부에서 트레이에 배치되어 이송되는 센서의 생산 정보를 획득하는 단계;
트랜스미터 정보 획득부에서 트레이에 배치되어 이송되는 트랜스미터의 생산 정보를 획득하는 단계;
정보 생성부에서 획득한 상기 센서의 생산 정보와 획득한 상기 트랜스미터의 생산 정보를 서로 매핑하여 품질 관리 정보를 생성하고 상기 품질 관리 정보를 판독할 수 있는 품질 관리 코드를 생성하는 단계;
라벨 생성부에서 생성한 품질 관리 코드를 구비하는 라벨을 생성하는 단계; 및
통신부에서 상기 품질 관리 정보를 관리 서버로 송신하는 단계를 포함하며,
상기 센서와 상기 트랜스미터는 동일한 트레이에 배치되고,
동일한 트레이에 배치된 센서와 트랜스미터는 상기 품질 관리 정보의 생성 후 서로 체결되어 연속혈당측정용 센서트랜스미터로 제조되며,
상기 품질 관리 정보는 상기 센서의 생산 정보, 상기 트랜스미터의 생산 정보 및 상기 센서트랜스미터를 제조한 제조 공장의 식별 정보를 포함하며,
상기 라벨은 상기 연속혈당측정용 센서트랜스미터가 장착되는 어플리케이터, 상기 어플리케이터의 내부 포장지, 상기 어플리케이터의 외부 포장지 중 적어도 어느 하나에 부착되는 것을 특징으로 하는 연속혈당측정용 센서트랜스미터의 제조 방법.
- 삭제
- 제 1 항에 있어서, 상기 품질 관리 코드는
상기 품질 관리 정보 중 상기 트랜스미터의 생산 정보만을 판독 가능하거나 상기 트랜스미터의 생산 정보와 상기 센서의 생산 정보 모두를 판독 가능하도록 생성되는 것을 특징으로 하는 연속혈당측정용 센서트랜스미터의 제조 방법.
- 삭제
- 제 1 항에 있어서, 상기 연속혈당측정용 센서트랜스미터의 제조 방법은
제어부에서 상기 품질 관리 정보를 상기 트랜스미터의 메모리에 저장하는 단계를 더 포함하며,
상기 메모리의 제1 영역에는 품질 관리 정보 중 트랜스미터의 생산 정보가 저장되고, 상기 메모리의 제2 영역에는 품질 관리 정보 중 센서의 생산 정보가 저장되는 것을 특징으로 하는 연속혈당측정용 센서트랜스미터의 제조 방법.
- 제 1 항, 제 3 항 및 제 5 항 중 어느 한 항에 있어서,
상기 센서에 형성된 센서 식별자를 판독하여 상기 센서의 생산 정보를 획득하는 것을 특징으로 하는 연속혈당측정용 센서트랜스미터의 제조 방법.
- 제 1 항, 제 3 항 및 제 5 항 중 어느 한 항에 있어서,
상기 트랜스미터의 외부 하우징에 형성된 트랜스미터 식별자를 판독하여 상기 트랜스미터의 생산 정보를 획득하는 것을 특징으로 하는 연속혈당측정용 센서트랜스미터의 제조 방법.
- 제 1 항, 제 3 항 및 제 5 항 중 어느 한 항에 있어서,
상기 트랜스미터의 생산 정보는 상기 트랜스미터의 메모리에 저장되어 있으며,
상기 메모리로부터 상기 트랜스미터의 생산 정보를 획득하는 것을 특징으로 하는 연속혈당측정용 센서트랜스미터의 제조 방법.
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200030306A KR102338667B1 (ko) | 2020-03-11 | 2020-03-11 | 연속혈당측정용 센서트랜스미터의 제조 방법 |
PCT/KR2021/002680 WO2021182797A2 (ko) | 2020-03-11 | 2021-03-04 | 연속혈당측정용 센서 트랜스미터의 제조 방법 |
US17/908,997 US20230101081A1 (en) | 2020-03-11 | 2021-03-04 | Method of manufacturing sensor transmitter for continuous blood glucose measurement |
JP2022552916A JP2023517018A (ja) | 2020-03-11 | 2021-03-04 | 連続血糖測定用センサートランスミッタの製造方法 |
EP21767302.9A EP4099241A4 (en) | 2020-03-11 | 2021-03-04 | METHOD FOR MANUFACTURING A SENSOR TRANSMITTER FOR CONTINUOUS GLUCOSE MONITORING |
AU2021235262A AU2021235262A1 (en) | 2020-03-11 | 2021-03-04 | Manufacturing method for sensor transmitter for continuous glucose monitoring |
CN202180017021.2A CN115151927A (zh) | 2020-03-11 | 2021-03-04 | 连续血糖测量用传感器发送机的制造方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200030306A KR102338667B1 (ko) | 2020-03-11 | 2020-03-11 | 연속혈당측정용 센서트랜스미터의 제조 방법 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20210114755A KR20210114755A (ko) | 2021-09-24 |
KR102338667B1 true KR102338667B1 (ko) | 2021-12-13 |
Family
ID=77670762
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020200030306A Active KR102338667B1 (ko) | 2020-03-11 | 2020-03-11 | 연속혈당측정용 센서트랜스미터의 제조 방법 |
Country Status (7)
Country | Link |
---|---|
US (1) | US20230101081A1 (ko) |
EP (1) | EP4099241A4 (ko) |
JP (1) | JP2023517018A (ko) |
KR (1) | KR102338667B1 (ko) |
CN (1) | CN115151927A (ko) |
AU (1) | AU2021235262A1 (ko) |
WO (1) | WO2021182797A2 (ko) |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4625857A (en) * | 1985-09-06 | 1986-12-02 | Z-Loda Corporation | Endless belt conveyor system having patterned belt transport surface |
EP3912551B1 (en) * | 2009-02-26 | 2023-08-30 | Abbott Diabetes Care, Inc. | Method of calibrating an analyte sensor |
US20130261927A1 (en) * | 2012-03-28 | 2013-10-03 | Delphi Technologies, Inc. | System and method to authenticate an automotive engine device |
KR102208696B1 (ko) * | 2014-05-13 | 2021-01-28 | 삼성전자주식회사 | 센서 데이터 획득 방법 및 그 장치 |
CA2996196C (en) * | 2015-08-31 | 2024-06-11 | Masimo Corporation | Wireless patient monitoring systems and methods |
US10470660B2 (en) * | 2015-09-10 | 2019-11-12 | Dexcom, Inc. | Transcutaneous analyte sensors and monitors, calibration thereof, and associated methods |
KR20180102714A (ko) * | 2017-03-07 | 2018-09-18 | 김선철 | 정품 인증 정보를 기반으로 하는 제품 이력정보 통합 관리 시스템 및 방법 |
EP3632321B1 (en) * | 2017-06-02 | 2024-12-18 | I-sens, Inc. | Sensor applicator assembly for continuous glucose monitoring system |
EP3928687B1 (en) * | 2017-10-24 | 2024-06-26 | Dexcom, Inc. | Wearable device with pre-connected analyte sensor |
KR102082357B1 (ko) * | 2018-02-14 | 2020-02-27 | 주식회사 아이센스 | 센서 사용 정보를 이용한 생체 정보의 관리 방법 |
-
2020
- 2020-03-11 KR KR1020200030306A patent/KR102338667B1/ko active Active
-
2021
- 2021-03-04 AU AU2021235262A patent/AU2021235262A1/en active Pending
- 2021-03-04 WO PCT/KR2021/002680 patent/WO2021182797A2/ko unknown
- 2021-03-04 US US17/908,997 patent/US20230101081A1/en active Pending
- 2021-03-04 JP JP2022552916A patent/JP2023517018A/ja active Pending
- 2021-03-04 EP EP21767302.9A patent/EP4099241A4/en active Pending
- 2021-03-04 CN CN202180017021.2A patent/CN115151927A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
US20230101081A1 (en) | 2023-03-30 |
WO2021182797A3 (ko) | 2021-11-11 |
JP2023517018A (ja) | 2023-04-21 |
AU2021235262A1 (en) | 2022-09-22 |
CN115151927A (zh) | 2022-10-04 |
EP4099241A2 (en) | 2022-12-07 |
KR20210114755A (ko) | 2021-09-24 |
EP4099241A4 (en) | 2024-02-21 |
WO2021182797A2 (ko) | 2021-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN208229182U (zh) | 测量装置、监测装置、和监测系统 | |
ES2741178T3 (es) | Método de gestión y utilización mejoradas de datos de diabetes utilizando conectividad inalámbrica entre pacientes y proveedores de atención sanitaria, y repositorio de información de gestión de la diabetes | |
KR100472092B1 (ko) | 이동통신단말기를 이용한 혈당측정장치 및 그 측정치를인터넷상의 서버에 전송하는 방법. | |
US6891936B2 (en) | Remote data control system and measuring data gathering method | |
DK2654564T3 (en) | CALIBRATION OF A PORTABLE DIABETES-control device which receives data from a continuous glucose monitor | |
JP5726286B2 (ja) | 自己完結型の体外診断装置 | |
ES2926670T3 (es) | Sistema de medición de analitos y procedimiento de inicialización | |
US20140024907A1 (en) | Method and system to indicate hyperglycemia or hypoglycemia for people with diabetes | |
US20120165639A1 (en) | Storage of calibration data at a continuous glucose monitor | |
IL193833A (en) | Body Fluid Tester, a system that includes this device and a system programming method | |
US20120330555A1 (en) | Analyte Testing System with Docking Station for Data Management | |
KR20120095037A (ko) | 혈당 측정의 정확도를 높이기 위한 장치 및 방법 | |
JP2003215122A (ja) | 小型検査機器、精度管理チップ及び小型検査機器の精度管理方法 | |
CN107102126B (zh) | 血糖计类别判定方法 | |
KR102338667B1 (ko) | 연속혈당측정용 센서트랜스미터의 제조 방법 | |
US20230298741A1 (en) | Method for providing guidance on use period of sensor | |
TWM536039U (zh) | 血糖檢測裝置 | |
CN103156575A (zh) | 自动无线传输式生理数据监测系统及其监测方法 | |
TWI644187B (zh) | 生理數據校時方法、系統、非暫態電腦可讀取媒體及電腦程式產品 | |
TWI552104B (zh) | 血糖值管理系統 | |
KR20110040348A (ko) | 혈당 이력 관리 장치 및 그 방법 | |
WO2023053120A1 (en) | System and method for collecting and optimizing medical data | |
TWM468734U (zh) | 智慧型雲端體重量測系統 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20200311 |
|
PA0201 | Request for examination | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20210119 Patent event code: PE09021S01D |
|
AMND | Amendment | ||
E601 | Decision to refuse application | ||
PE0601 | Decision on rejection of patent |
Patent event date: 20210831 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20210119 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |
|
X091 | Application refused [patent] | ||
PG1501 | Laying open of application | ||
AMND | Amendment | ||
PX0901 | Re-examination |
Patent event code: PX09011S01I Patent event date: 20210831 Comment text: Decision to Refuse Application Patent event code: PX09012R01I Patent event date: 20210419 Comment text: Amendment to Specification, etc. |
|
PX0701 | Decision of registration after re-examination |
Patent event date: 20211206 Comment text: Decision to Grant Registration Patent event code: PX07013S01D Patent event date: 20211101 Comment text: Amendment to Specification, etc. Patent event code: PX07012R01I Patent event date: 20210831 Comment text: Decision to Refuse Application Patent event code: PX07011S01I Patent event date: 20210419 Comment text: Amendment to Specification, etc. Patent event code: PX07012R01I |
|
X701 | Decision to grant (after re-examination) | ||
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20211208 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20211209 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
PR1001 | Payment of annual fee |
Payment date: 20240911 Start annual number: 4 End annual number: 4 |